Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-15-054904

Director sold 10,000 shares at $7.26 ($72,600)

  • Director acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Kraus Al Director 2015-09-10 Option exercise +10,000 $0.88 $8,750 65,746 D
Kraus Al Director 2015-09-10 Sale −10,000 $7.26 $72,600 55,746 D
Derivatives
Kraus Al Director 2015-09-10 Option exercise · Stock Option −10,000 56,773 D
Open-market sales · 10,000 sh · avg $7.26 · $72,600
Loading xslF345X03/v420119_4.xml…